Tirzepatide Weight Loss Medication
Tirzepatide is the first truly revolutionary and game changing medication in over 60 years! On November 8, 2023, the FDA approved Zepbound (Tirzepatide) for weight loss after extensive studies for safety and efficacy in non-diabetic patients. The results were astounding!
Since Tirzepatide is a dual receptor medication that is injected once a week, it aids in helping us feel full easier, decreases appetite, and increases insulin sensitivity (meaning burning glucose for energy like we do during exercise instead of making fat).
WANT TO LEARN MORE ABOUT TIRZEPATIDE?
Tirzepatide (Mounjaro) has been on the market for the treatment of diabetes since 2022, but studied since 2016. After doing complete studies with patients all over the world, it was deemed the most revolutionary medication for weight loss in decades. Now we have it, and with Dr. Knighton’s expertise and purity requirement, you will get the best product and knowledge from someone you can trust. You won’t get the treatment Dr. Knighton provides anywhere and this is why patients travel from all over the U.S. just to see him
Dr. Knighton’s Approach
Dr. Knighton’s Approach
Dr. Knighton uses Tirzepatide with his patients in a way that doesn’t cause the side effects to the degree that semaglutide did. Dr. Knighton’s approach leads to better results with less medication as Dr. Knighton personalizes a plan that is based on you and not a “formula” or “algorithm.” In fact, Dr. Knighton is using it personally, has effectively lost weight/body fat. Dr. Knighton calls it the “game-changer in weight loss treatment” and says “I have been waiting my entire career for a revolutionary medication like this to come along.”